Previous Article | Next Article 
Infect Immun, July 1998, p. 3080-3087, Vol. 66, No. 7
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Oral Vaccination against Tetanus: Comparison of the
Immunogenicities of Salmonella Strains Expressing
Fragment C from the nirB and htrA
Promoters
Mark
Roberts,1,*
Jingli
Li,2
Andrew
Bacon,2 and
Steven
Chatfield2
Department of Veterinary Pathology, Glasgow
University Veterinary School, Glasgow G61 1QH,1
and
Vaccine Research Unit, Medeva, Department of
Biochemistry, Imperial College of Science, Technology and Medicine,
London SW7 2AZ,2 United Kingdom
Received 6 November 1997/Returned for modification 7 January
1998/Accepted 8 April 1998
We have found the in vivo-regulated nirB promoter
(PnirB) to be effective for directing
expression of a number of antigens in salmonella in vivo. We wished to
determine if other in vivo-regulated promoters have utility for antigen
expression in salmonella and to compare the effectiveness of these
promoters with that of PnirB. To this end, we
have devised a scheme that allows the promoter element of the
PnirB-fragment C plasmid pTETnir15 to be
swapped with other promoters of interest. We demonstrate the usefulness
of this system by replacing PnirB with
PhtrA to create plasmid pTEThtrA1.
htrA is a stress response gene that is required for
virulence of salmonella in mice and survival within macrophages.
Expression of fragment C in Salmonella typhimurium BRD509
(aroA aroD) harboring pTEThtrA1 (strain BRD937)
correlated with growth temperature in vitro. A comparison was made of
the immune responses to fragment C elicited in mice immunized orally
with BRD937 or BRD847 (BRD509/pTETnir15) or subcutaneously with
purified fragment C plus alhydrogel. High levels of anti-fragment C
antibodies that persisted for at least 12 weeks were present in all
groups of mice. Vaccination with BRD937 was the most effective means of
immunization: the serum immunoglobulin G (IgG), IgA, and IgM
anti-fragment C titers were higher in the BRD937-immunized mice
throughout the duration of the study than in mice in the other groups.
The kinetics of the serum anti-fragment C responses were different in
different groups. The response was most rapid in the BRD937 group, with
the titers almost at peak levels at 2 weeks postimmunization. Only the
mice immunized with BRD937 or BRD847 developed an intestinal IgA
response to fragment C. Again, the response was superior in the BRD937 group. The peak of the intestinal response was delayed with respect to
the serum response. Analysis of the IgG subtype response to fragment C
revealed a dominant IgG2a response in the salmonella-immunized mice,
indicating a type 1 helper T-cell response to fragment C, whereas the
major subtype in the group parenterally immunized with fragment C plus
alhydrogel was IgG1. The IgG1/IgG2a ratio was much higher in sera of
BRD937-immunized mice than in sera of BRD847-immunized mice. At 15 to
20 weeks after immunization, the mice immunized with BRD937 or BRD847
were solidly immune to tetanus toxin and salmonella. The immune
responses to fragment C seen in mice immunized with BRD937 are the
strongest we have observed and indicate that the htrA
promoter may be very useful for expressing foreign antigens in
salmonella vaccine strains.
*
Corresponding author. Mailing address: Department of
Veterinary Pathology, Glasgow University Veterinary School, Bearsden Road, Glasgow G61 1QH, United Kingdom. Phone: 0141 330 5780. Fax: 0141 330 5602. E-mail: M.Roberts{at}vet.gla.ac.uk.
Infect Immun, July 1998, p. 3080-3087, Vol. 66, No. 7
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Xin, W., Wanda, S.-Y., Li, Y., Wang, S., Mo, H., Curtiss, R. III
(2008). Analysis of Type II Secretion of Recombinant Pneumococcal PspA and PspC in a Salmonella enterica Serovar Typhimurium Vaccine with Regulated Delayed Antigen Synthesis. Infect. Immun.
76: 3241-3254
[Abstract]
[Full Text]
-
Stephens, J. C., Darsley, M. J., Turner, A. K.
(2006). Stabilization of a Plasmid Coding for a Heterologous Antigen in Salmonella enterica Serotype Typhi Vaccine Strain CVD908-htrA by Using Site-Specific Recombination. Infect. Immun.
74: 4383-4386
[Abstract]
[Full Text]
-
Chen, A. Y., Fry, S. R., Forbes-Faulkner, J., Daggard, G., Mukkur, T. K. S.
(2006). Evaluation of the immunogenicity of the P97R1 adhesin of Mycoplasma hyopneumoniae as a mucosal vaccine in mice.. J Med Microbiol
55: 923-929
[Abstract]
[Full Text]
-
Farn, J., Roberts, M.
(2004). Effect of Inactivation of the HtrA-Like Serine Protease DegQ on the Virulence of Salmonella enterica Serovar Typhimurium in Mice. Infect. Immun.
72: 7357-7359
[Abstract]
[Full Text]
-
Capozzo, A. V. E., Cuberos, L., Levine, M. M., Pasetti, M. F.
(2004). Mucosally Delivered Salmonella Live Vector Vaccines Elicit Potent Immune Responses against a Foreign Antigen in Neonatal Mice Born to Naive and Immune Mothers. Infect. Immun.
72: 4637-4646
[Abstract]
[Full Text]
-
Vivas, J., Carracedo, B., Riano, J., Razquin, B. E., Lopez-Fierro, P., Acosta, F., Naharro, G., Villena, A. J.
(2004). Behavior of an Aeromonas hydrophila aroA Live Vaccine in Water Microcosms. Appl. Environ. Microbiol.
70: 2702-2708
[Abstract]
[Full Text]
-
Chen, H., Schifferli, D. M.
(2003). Construction, Characterization, and Immunogenicity of an Attenuated Salmonella enterica Serovar Typhimurium pgtE Vaccine Expressing Fimbriae with Integrated Viral Epitopes from the spiC Promoter. Infect. Immun.
71: 4664-4673
[Abstract]
[Full Text]
-
Londono-Arcila, P., Freeman, D., Kleanthous, H., O'Dowd, A. M., Lewis, S., Turner, A. K., Rees, E. L., Tibbitts, T. J., Greenwood, J., Monath, T. P., Darsley, M. J.
(2002). Attenuated Salmonella enterica Serovar Typhi Expressing Urease Effectively Immunizes Mice against Helicobacter pylori Challenge as Part of a Heterologous Mucosal Priming-Parenteral Boosting Vaccination Regimen. Infect. Immun.
70: 5096-5106
[Abstract]
[Full Text]
-
Bumann, D.
(2001). Regulated Antigen Expression in Live Recombinant Salmonella enterica Serovar Typhimurium Strongly Affects Colonization Capabilities and Specific CD4+-T-Cell Responses. Infect. Immun.
69: 7493-7500
[Abstract]
[Full Text]
-
Bumann, D.
(2001). In Vivo Visualization of Bacterial Colonization, Antigen Expression, and Specific T-Cell Induction following Oral Administration of Live Recombinant Salmonella enterica Serovar Typhimurium. Infect. Immun.
69: 4618-4626
[Abstract]
[Full Text]
-
Roberts, M., Chatfield, S., Pickard, D., Li, J., Bacon, A.
(2000). Comparison of Abilities of Salmonella enterica Serovar Typhimurium aroA aroD and aroA htrA Mutants To Act as Live Vectors. Infect. Immun.
68: 6041-6043
[Abstract]
[Full Text]
-
Chen, H., Schifferli, D. M.
(2000). Mucosal and Systemic Immune Responses to Chimeric Fimbriae Expressed by Salmonella enterica Serovar Typhimurium Vaccine Strains. Infect. Immun.
68: 3129-3139
[Abstract]
[Full Text]
-
Sydenham, M., Douce, G., Bowe, F., Ahmed, S., Chatfield, S., Dougan, G.
(2000). Salmonella enterica Serovar Typhimurium surA Mutants Are Attenuated and Effective Live Oral Vaccines. Infect. Immun.
68: 1109-1115
[Abstract]
[Full Text]
-
John, M., Crean, T. I., Calderwood, S. B., Ryan, E. T.
(2000). In Vitro and In Vivo Analyses of Constitutive and In Vivo-Induced Promoters in Attenuated Vaccine and Vector Strains of Vibrio cholerae. Infect. Immun.
68: 1171-1175
[Abstract]
[Full Text]
-
Dunstan, S. J., Simmons, C. P., Strugnell, R. A.
(1999). Use of In Vivo-Regulated Promoters To Deliver Antigens from Attenuated Salmonella enterica var. Typhimurium. Infect. Immun.
67: 5133-5141
[Abstract]
[Full Text]
-
Roberts, M., Bacon, A., Li, J., Chatfield, S.
(1999). Prior Immunity to Homologous and Heterologous Salmonella Serotypes Suppresses Local and Systemic Anti-Fragment C Antibody Responses and Protection from Tetanus Toxin in Mice Immunized with Salmonella Strains Expressing Fragment C. Infect. Immun.
67: 3810-3815
[Abstract]
[Full Text]